Internal Medicine, Rheumatology · Lexington, KY
NPI
1982658902
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1221 S Broadway
Lexington, KY, 40504
Phone (859) 258-4450
Groups this clinician bills Medicare through
Medicare paid, 2024
$513K
34,711 services
Medicare patients, 2024
720
Average age 73
Drug cost, 2024
$6.5M
7,318 prescriptions
Company payments, 2025
$497
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed H Abbas was code J1010 (injection, methylprednisolone acetate, 1 mg), 6,783 times for 70 patients. In total Syed H Abbas billed 34,711 services in 37 codes, and Medicare paid $513K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,783 | 70 | $0.10 | $682 |
| J0897 Injection, denosumab, 1 mg | Office | 4,200 | 44 | $20.44 | $86K |
| 99213 Office E&M - Established | Office | 909 | 550 | $54.97 | $50K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 843 | 12 | $0.22 | $186 |
| 99214 Office E&M - Established | Office | 424 | 255 | $83.54 | $35K |
| 96365 Intravenous Infusion, Hydration | Office | 198 | 25 | $18.05 | $3,574 |
| 20610 Joint Injection | Office | 139 | 64 | $45.84 | $6,372 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 107 | 92 | $12.06 | $1,291 |
| 99204 Office E&M - New | Office | 94 | 94 | $95.32 | $8,961 |
| 96372 Injection Administration | Office | 93 | 55 | $8.90 | $828 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 80 | 16 | $4.38 | $351 |
| 96413 Chemotherapy Administration | Office | 71 | 15 | $85.55 | $6,074 |
| 96375 Injection Administration | Office | 24 | 11 | $10.50 | $252 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 21 | 21 | $2.88 | $60.48 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 17 | 17 | $5.42 | $92.16 |
By year: 2022 $165K for 5,216 services; 2023 $314K for 16,041 services; 2024 $513K for 34,711 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed H Abbas prescribed most often to Medicare patients was Prednisone, with 1,573 prescriptions and refills. In total Syed H Abbas wrote 7,318 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,573 | 3,900 | 476 | $14K |
| Hydroxychloroquine Sulfate Generic | 975 | 2,596 | 285 | $30K |
| Methotrexate Methotrexate Sodium | 861 | 2,057 | 235 | $18K |
| Gabapentin Generic | 315 | 424 | 61 | $2,164 |
| Allopurinol Generic | 274 | 756 | 80 | $1,813 |
| Enbrel Sureclick Etanercept | 273 | 293 | 36 | $2.1M |
| Tramadol Hcl Generic | 236 | 236 | 42 | $828 |
| Celecoxib Generic | 206 | 489 | 56 | $9,282 |
| Sulfasalazine Generic | 151 | 335 | 42 | $2,976 |
| Pilocarpine Hcl Generic | 148 | 240 | 34 | $8,361 |
| Methylprednisolone Generic | 139 | 159 | 86 | $932 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 133 | 133 | 23 | $1,832 |
| Alendronate Sodium Generic | 116 | 287 | 44 | $920 |
| Meloxicam Generic | 109 | 219 | 40 | $559 |
| Duloxetine Hcl Generic | 88 | 220 | 24 | $1,132 |
Brand drugs: - claims; generic drugs: 6,162 claims; opioid claims: 392.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed H Abbas $497 ($497 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novartis Pharmaceuticals Corporation with $85.49.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 3 | $85.49 |
| Amgen Inc. AMGN | 3 | $64.23 |
| UCB, Inc. UCB.BR | 2 | $54.96 |
| Sobi, Inc SOBI.ST | 2 | $51.21 |
| Janssen Biotech, Inc. JNJ | 2 | $45.37 |
| Pfizer Inc. PFE | 2 | $37.58 |
| Shionogi Inc 4507.T | 1 | $26.71 |
| GlaxoSmithKline, LLC. GSK | 1 | $25.33 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $24.04 |
| Genzyme Corporation SNY | 1 | $23.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.